7/1/2023 0 Comments Medicare copay relief![]() The programs are not valid for patients receiving assistance from any other third party, including charitable organizations, if assistance is for the same expenses covered by the programs. The programs are not valid if the costs are eligible to be reimbursed in their entirety by private insurance plans or other programs. The amount of each of the program’s benefits cannot exceed the patient’s out-of-pocket expenses for the cost of the drug or administration fees associated with CIMERLI™. After reaching the maximum benefit for either program, the patient will be responsible for all remaining out-of-pocket expenses. Patients may participate in the programs as long as patient re-enrolls as required by Coherus BioSciences and continues to meet all of the eligibility requirements for each program during participation in the programs. Re-enrollment in the programs is required at regular intervals. The program benefits will reset every January 1st. Under the CIMERLI™ Injection Co-Pay program, if a patient incurs a co-pay obligation for the administration of CIMERLI™, and meets all eligibility requirements, Coherus shall subsidize the cost of administration up to $1,000 per calendar year. Under the CIMERLI™ Drug Co-Pay program, if a patient incurs a co-pay obligation for the cost of CIMERLI™, and meets all eligibility requirements, Coherus shall subsidize the cost of drug up to $15,000 per calendar year. Participating patients, pharmacies, physician offices and hospitals may use Coherus’s patient services web portal or send completed enrollment forms to 1-87 to enroll patients. To receive co-pay assistance for drug or administration co-pay costs, the provider, patient, or caregiver must enroll eligible individual within 180 days after the date of service for which the subsidy is sought. Patients must enroll separately as needed. This is not health insuranceĬoherus’s Drug Co-pay Program and Injection Co-pay Program are different programs with unique eligibility for each. CIMERLI™ co-pay program subject to change or discontinuation without notice.It is not valid for cash-paying patients or where prohibited by law.Other restrictions apply, see Terms & Conditions †.Not seek reimbursement from any third party, including payers, charitable foundations, or flexible spending account (FSAs) or healthcare savings accounts (HSAs) for all or any part of the benefit received by Coherus through this program.Not covered by any federal, state, or government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, Veterans Affairs, Department of Defense, or TRICARE.If a resident of Massachusetts, injection administration may only be paid directly to the patient.For Administration: Not a resident or get treatments in Minnesota, Rhode Island.Over the age of 18 years old and a US resident.Have commercial (private or non-governmental) health insurance that covers the medication costs of CIMERLI™. ![]() Be prescribed CIMERLI™ for a medically appropriate purpose consistent with its FDA-approved labeling within 180 days of program enrollment.* Drug and Injection Co-Pay Eligibility Criteria: ![]()
0 Comments
Leave a Reply. |